Background: Choline and betaine status have previously been associated with symptoms of depression. However, the relation of maternal plasma choline and betaine concentrations in pregnancy to peripartum maternal mood is unknown. 
INTRODUCTION
Approximately 13-19% of all mothers suffer from depression or anxiety during or after pregnancy (Gavin et al., 2005; O'Hara & Swain, 1996) . This can lead to disturbing consequences for both the mother and her offspring. Perinatal depression has been associated with a higher risk of preeclampsia, loss of productivity, increased health care use, unfavorable parenting practices, impaired mother-infant bonding, and increased risks for depressive symptoms and central adiposity in the offspring (Andersson, Sundstrom-Poromaa, Wulff, Astrom, & Bixo, 2004; Gentile, 2017) .
Neurotransmitter levels in the brain can be influenced by dietary nutrients; it has been shown that dietary choline intake can alter the neurotransmitter acetylcholine levels (Blusztajn & Wurtman, 1983) .
There is clinical evidence for a relation between levels of both choline and betaine and clinical status in depression. Choline is found in high concentrations in animal products, such as meat, liver, and eggs (Zeisel, Mar, Howe, & Holden, 2003) , and can be synthesized endogenously.
Choline is also the precursor for betaine and phosphatidylcholine that are involved in methylation processes and membrane synthesis, respectively.
Choline is less investigated in relation to mental well-being as compared with nutrients associated with the synthesis of monoamines such as folate and tryptophan (Miller, 2008; Papakostas, Cassiello, & Iovieno, 2012; Réus et al., 2015) . Results from studies examining choline and mental well-being have been contradictory and limited by sample size (Cohen, Lipinski, & Altesman, 1982; Davis, Hollister, & Berger, 1979; Stoll et al., 1996; Tamminga, Smith, Chang, Haraszti, and Davis, 1976; Vida, Gauthier, & Gauthier, 1989) . Most studies have focused on clinical patient groups (Cohen et al., 1982; Davis et al., 1979; Olvera et al., 2010; Stoll et al., 1996; Tamminga et al., 1976; Vida et al., 1989) , such that the association between choline status and mood across the population is unknown. To date, choline supplementation reduced depressive mood symptoms in six patients with bipolar disorder (Stoll et al., 1996) and improved symptoms in 11 patients with mania (Cohen et al., 1982) . A case-control study in adolescents with major depression reported lower brain phosphatidylcholine and glycerol-3-phosphocholine concentrations compared to healthy controls (Olvera et al., 2010) , while a cross-sectional study reported inverse associations between plasma choline concentrations and anxiety levels in generally healthy men and women (Bjelland, Tell, Vollset, Konstantinova, & Ueland, 2009 ). In contrast, choline or lecithin (a source of choline) supplementation trials reported an increase in depressive symptoms in two patients with tardive dyskinesia (Tamminga et al., 1976) and nine patients with schizophrenia (Davis et al., 1979) . Studies on betaine, an important methyl-donor, in relation to mental well-being are even scarcer. Two studies reported that betaine supplementation in combination with S-adenosylmethionine (SAMe) was a more effective treatment than SAMe alone in patients with mild-to-moderate depression (Di Pierro, Orsi, & Settembre, 2015; .
No studies to date have been conducted in pregnant women, yet this may be important as pregnant women have a higher dietary choline requirement to meet the needs of the growing fetus (Institute of Medicine [IOM], 1998) . Most pregnant women in a U.S. sample were unable to meet these extra needs (Jensen, Batres-Marquez, Carriquiry, & Schlalinske, 2007) , potentially increasing their risk of deficiency-related disorders such as nonalcoholic fatty liver disease or birth defects (Zeisel, 2013) and initiating a discussion for the need of choline supplementation during pregnancy (Jiang, West, & Caudill, 2014; Zeisel, 2013) .
The relation between nutrient levels and maternal mental wellbeing is an important research topic, as nutrient levels represent a highly realistic target for both prevention and intervention. The relationship between choline and betaine status during pregnancy and mental well-being has been largely unexplored. In this study, we, therefore, aimed to examine maternal choline and betaine concentrations during pregnancy in relation to ante-and postnatal depressive symptoms and anxiety in a large cohort of pregnant women in Singapore.
METHODS

Study design and population
The Growing Up in Singapore Toward healthy Outcomes (GUSTO) study is a large multiethnic Asian mother-offspring cohort study aimed at evaluating the role of early-life exposures on later-life metabolic disease risks (clinicaltrials.gov; NCT01174875). Details on study aims and design have been described elsewhere (Soh et al., 2014) . Briefly, 1,247 pregnant women were recruited from two major maternity units in Singapore between June 2009 and September 2010. Participants were either Chinese, Malay, or Indian Singaporean citizens or permanent residents of which the parents and spouse's parents had to be from a homogenous ethnic background. Participants were eligible when aged between 19 and 50, having the intention to deliver in the one of the study maternity units, be living in Singapore for next 5 years, and willing to donate cord, placenta, and cord blood at delivery. The major exclusion criterion was having preexisting serious health conditions including self-reported type I diabetes, psychoses, or receiving chemotherapy or psychotropic drugs. The study was approved by the medical ethical review boards of National University Hospital and KK Women's and Children's Hospital. Prior to recruitment, all participants gave written informed consent.
Maternal plasma nutrient concentrations
Blood samples at 26-28 weeks gestation were processed within 4 hr and stored at −80 • C prior to analysis. Plasma concentrations of free choline and betaine were analyzed by high-performance liquid chromatography (1100 series, Agilent Technologies, Santa Clara, USA) and tandem mass spectrometry (API 3000, Ab Sciex, Toronto, Canada; Midttun, Kvalheim, & Ueland, 2013) . The within-and between-day imprecision coefficients of variation for these metabolites were between 4 and 10% (Midttun et al., 2013) . Plasma folate concentrations were assessed by competitive electrochemiluminescence immunoassay (ADVIA Centaur Immunoassay System, Siemens, München, Germany): between-assay coefficients of variation were between 6 and 11%.
Maternal mental state
At 26-28 weeks gestation and at 3 months postdelivery, all participants self-administered the Edinburgh Postnatal Depression Scale (EPDS) and the State-Trait Anxiety Inventory (STAI). The EPDS is a 10-item screening tool scored between 0 and 3 that rates the intensity of depressive symptoms present in the past 7 days (Cox, Holden, & Sagovsky, 1987) . EPDS is considered valid for use in multiple cultures during and after pregnancy (Gibson, McKenzie-McHarg, Shakespeare, Price, & Gray, 2009; Kozinszky & Dudas, 2015) . Pregnant women with antenatal EPDS score ≥ 15 was considered as having probable depression during pregnancy, whereas postnatal EPDS score ≥ 13 indicated a probable depression postpartum (Chen et al., 2011; Gibson et al., 2009 ). The term probable depression was used, as the EPDS examines mood in terms of symptom severity rather than clinical diagnoses.
The STAI consists of two subscales (State and Trait anxiety) with each 20 items scored 0-4 to assess anxiety levels (Spielberger, Gorsuch, Lushene, Vagg, & Jacobs, 1983) . The STAI has shown construct validity (Meades & Ayers, 2011) and was considered reliable within the GUSTO cohort (Qiu et al., 2013) . STAI-state reflects a transitory emotional state and may, therefore, fluctuate over time, whereas STAI-trait represents a relatively stable individual tendency of anxiety. In the present study, only the STAI-state measures were used. The top 75th percentiles of the study sample was used to define high levels of anxiety (STAI-state antenatal score ≥ 41 and postnatal score ≥ 40), as suggested by others (Nasreen, Kabir, Forsell, & Edhborg, 2010; Teixeira, Fisk, & Glover, 1999) .
Covariates
Ethnicity and maternal age were collected during the recruitment phase at 12-14 weeks of gestation. Detailed information on demographics and maternal lifestyle including smoking habits, income, and educational level were collected during the clinic visit at 26-28 weeks of gestation. Educational level was categorized in low, intermediate, and high, and income was categorized as <S$1,999, S$2,000-5,999, >S$6,000. Regular prepregnancy smokers (y/n) were defined as smoking once a day for a year or longer.
Statistical analyses
Of 1,247 recruited pregnant women, 949 had their plasma concentrations of choline and betaine measured and had complete data for antenatal STAI and EPDS (Fig. 1 ). For the postnatal analyses, 689 participants had complete data for nutrient markers, STAI, and EPDS.
Maternal characteristics were presented according to antenatal probable depression and anxiety. P values for difference were computed using an independent t-test for continuous variables and F-test statistic for categorical variables. Linearity of the associations were first examined by use of restricted cubic splines and they indicated linear associations (all P nonlinearity > .10). We then modeled EPDS and STAI-state scores continuously using linear regression models. To study a dose-response relationship, we used Poisson regression models with robust variance to calculate the prevalence risk ratios (PR) of having probable depression or anxiety according to tertiles (choline: T1 5.4-8.3 mol/L, T2 8.3-9.7 mol/L, T3 9.7-14.8 mol/L; betaine: T1 5.3-11.9 mol/L, T2 11.9-14.0 mol/L, T3 14.0-25.0 mol/L). PRs were used because odds ratios could overestimate the strength of the association in non case-control studies when the disease is not rare (Coutinho, Scazufca, & Menezes, 2008; Thompson, Myers, & Kriebel, 1998) . Linear trends were modeled using the median of tertiles as a continuous variable in the model. We presented the following three models: Model 1: unadjusted; Model 2: adjusting for regular prepregnancy smoking, maternal age, ethnicity, educational level, and income;
Model 3: adjusting for confounders in Model 2, plus plasma folate and choline or betaine concentrations. When analyzing postnatal mental well-being, we additionally included antenatal mental state scores as a covariate. In sensitivity analyses, we further studied the potential confounding effects of plasma total omega-3, total omega-6 fatty acid concentrations ( g/mL) (Chong et al., 2015) , and alcohol use (y/n) (Moss, Goldstein, Chen, & Yi, 2015) . In addition, we included an interaction term of nutrient status with ethnicity and folate status in the relationship with antenatal mental well-being. Lastly, correlations between plasma choline concentrations and food groups as assessed by a 24-hr recall at 26-28 weeks gestation were examined to explore the dietary sources of choline in this study sample.
Missing values for income (n = 63), educational level (n = 16), prepregnancy smoking (n = 1), and folate concentration (n = 1) were imputed for 20 times and results were pooled. All analyses were performed in STATA version 14.1 (StataCorp LP, USA) and statistical significance was set at P < .05.
RESULTS
Mean choline and betaine concentrations in the antenatal study sample were 9.2 mol/L (SD = 1.6) and 13.1 mol/L (SD = 2.7), respectively.
The prevalence of probable depression and mean (SD) EPDS scores in our study sample was 7% and 7.4 (4.5), respectively, during the antenatal period and 10% and 6.3 (4.7), respectively, during the postnatal period. For probable anxiety, the prevalence and mean (SD) STAIstate scores was 27% and 33.9 (10.0), respectively, during the antenatal period and 25% and 33.7 (10.2), respectively, during the postnatal period. Women who suffered from antenatal probable depression had higher plasma betaine concentrations, lower plasma folate concentrations, were younger, more likely to smoke regularly before pregnancy, had a lower education level and a lower income compared to nondepressive women (Table 1) . Mean choline concentrations were similar among the women with (9.4 ± 1.7) and without (9.1 ± 1.6; P = .195) probable depression. Women, who had probable antenatal anxiety had higher plasma choline concentrations, were younger, more likely to smoke regularly before pregnancy and had a lower educational level, income, and plasma total omega-3 concentrations. When examining the postnatal study sample, we observed similar trends in the sample characteristics (Supporting Information Table S1 ). In the dose-response analyses, the mean scores for EPDS and STAIstate differed significantly across tertiles of choline during pregnancy (P EPDS = .006; P STAI-state = .021; Table 3 ), but not postpartum (P EPDS = .206; P STAI-state = .652; Table 4 
Betaine and mental well-being
Using linear regression models, we observed a trending positive association between plasma betaine and depression scores [ = .10 EPDS score [95% CI: 0.00-0.21] per mciromole per liter) ( 
Sensitivity analyses
Sensitivity analyses showed no effect modification of ethnicity or plasma folate status in the relationship between plasma choline or betaine status on ante-and postnatal mental well-being. Additional adjustment for alcoholic beverage use, plasma total omega-3, or total omega-6 fatty acid concentrations did not change our results significantly (data not shown). We found positive correlation coefficients between plasma choline and dietary intake of eggs (r = .17), bread (r = .13), dairy (r = −.10), fish (r = .07), and poultry (r = .02).
DISCUSSION
To our knowledge, this is the first study to report on the relation between higher antenatal plasma choline concentrations and antenatal depression and anxiety (mental well-being) in a peripartum cohort.
No associations were observed between plasma betaine and antenatal mental well-being, as well as between choline or betaine concentrations and postnatal mental well-being. Choline ( mol/L) 9.1 ± 1.6 9.4 ± 1.7 .195 9.1 ± 1.6 9.3 ± 1.7 .035
Betaine ( mol/L) 13.1 ± 2.6 13.8 ± 3.3 .044 13.1 ± 2.6 13. These trials either supplemented with choline or increased neural acetylcholine levels by inhibition or knock-out of the breakdown of neural acetylcholine (i.e., cholinesterase) or by blocking acetylcholine receptors. Unfortunately, no choline concentrations were reported in these studies and thus direct comparison with our concentrations was not possible.
In contrast to our findings, choline supplementation has been shown to improve depression and mania scores in patients with mental disorders (Brown & Gabrielson, 2012; Cohen et al., 1982; Stoll et al., 1996) .
These trials administered 2-6 g choline/day, which corresponds to 4-12 times the adequate intake of dietary choline of 450 mg/day. These doses are likely to be considerably higher compared to the dietary choline intake in our study. Strikingly, a cross-sectional analysis in middle-aged and elderly adults with similar plasma choline concentrations (range 4.1-24.7 mol/L) reported an inverse association between plasma choline concentrations and anxiety as measured with the Hospital Anxiety and Depression scale (Bjelland et al., 2009 ). These associations were, however, not observed in women after stratification for sex.
Unlike other methyl-donor nutrients such as folate and SAMe that have been shown to be inversely associated with depressive symptoms (Miller, 2008; Papakostas et al., 2012) , we did not observe a significant association between betaine and antenatal or postnatal mental wellbeing. Our finding was supported by the results from a cross-sectional study in Norwegian adults that also observed no associations between plasma betaine concentrations and mental well-being (Bjelland et al., 2009 ).
Mechanism
Depression has been considered a complex and multifactorial disease of unknown etiology. However, research in animals and humans has elucidated some insight into possible mechanisms through which choline might exert its effect on depressive symptoms and anxiety levels.
A plausible mechanism through which choline may play a role in depression and anxiety is via neural acetylcholine concentrations.
Cholinesterase inhibitors, which inhibit breakdown of acetylcholine in extracellular space, and acetylcholine receptor antagonists, induced depressive symptoms, presumably by increasing neural acetylcholine (Dagytė, Boer, Den, & Trentani, 2011; Janowsky et al., 1994) . These results were confirmed in mice studies showing that local administration of physostigmine or knockdown of acetylcholinesterase increased anxiety-and depression-like behaviors (Mineur et al., 2013) . Additionally, choline supplementation upregulated alpha7 nicotinic acetylcholine receptor levels in the hippocampus of rats, whereas stress altered levels of these nicotinic acetylcholine receptor levels (Schulz et al., 2014) .
Alterations in the hypothalamic-pituitary-adrenal (HPA) axis might also play a role. Acetylcholine receptors, which are located on the presynaptic terminals of corticotrophin releasing factor neurons, have shown to affect key components of the HPA axis and HPA axis function alterations such as increased cortisol and adrenocorticotropic hormone release have been seen in depressed patients (Janowsky, & Overstreet, 2000; Philip et al., 2010) . In healthy and psychiatric patients, physostigmine, a cholinesterase inhibitor, has shown to induce HPA axis resulting in increases in ACTH, -endorphin, and cortisol immunoreactivities (Janowsky & Risch, 1984; Risch, Janowsky, & Gillin, 1983) . Furthermore, mecamylamine, an acetylcholine receptor antagonist, can prevent corticotropin releasing factor release (Raber, Koob, & Bloom, 1995) . Moreover, in rats on a choline deficient diet, the HPA response to auditory stress was impaired, which was partially corrected by choline supplementation (Sithichoke, Malasanos, & Marotta, 1978) . Lastly, higher maternal dietary choline intake (930 vs. 480 mg/day) lowered offspring circulating cortisol by altering the methylation state of cortisol-regulating genes in the placenta and fetal compartments (Jiang et al., 2014) .
Another plausible mechanism might be via mitochondrial dysfunction that occurs in certain more serious neuropsychiatric disorders (Morris & Berk, 2015; Müller et al., 2015) , whereby more choline may be available for transformation into phospholipids or acetylcholine as choline is oxidized to betaine in the mitochondrion. Patients with mitochondrial dysfunction showed higher levels of hippocampal glycero-3-phosphocholine, a type of phospholipid, than controls (Anglin, Rosebush, Noseworthy, Tarnopolsky, & Mazurek, 2012) . Higher levels of glycero-3-phosphocholine have also been associated with anxiety and bipolar disorders (Anglin et al., 2012; Senaratne, Milne, MacQueen, & Hall, 2009 ).
Strengths and limitations
Important strengths of the present study were the fairly large sample size and the availability of plasma folate, vitamin B12, and omega-3 fatty acids concentrations. These nutrients were included in our analyses, because they have previously been associated with depression and anxiety (Chong et al., 2014 (Chong et al., , 2015 . Furthermore, we used plasma choline and betaine concentrations, thus eliminating the possibility of recall bias of dietary intake as compared to commonly used dietary assessment methods (Kipnis et al., 2003) . These plasma concentrations reflect both dietary intake and endogenous syntheses. This said, a limitation is that we are uncertain about the main dietary sources of choline. It is likely that our reported choline concentrations were influenced by dietary intake, as most prenatal supplements do not contain sources of choline (Zeisel, 2013 Model 1: unadjusted. Model 2: adjusted for prepregnancy regular smoking (y/n), maternal age (y), ethnicity (Chinese, Malay, Indian), educational level (primary and secondary, post-secondary, university), income (<S$1,999, 2,000-5,999, >S$6,000) , and antenatal scores. plasma choline concentrations may be influenced by gut microbiota, as some evidence suggests the existence of acetylcholine-producing bacteria and the breakdown of choline into trimethylamine (Sandhu et al., 2017; Smallwood, Allayee, & Bennett, 2016) . Unfortunately no data on microbiome in mothers was available to further examine these possible interactions with our plasma choline concentrations. Another important limitation was the partial cross-sectional design of our study that limits causal inferences. Consequently, we cannot exclude the possibility of a bidirectional relationship where depressive symptoms during pregnancy lead to an altered diet and subsequent nutrient status.
In addition, the plasma markers were only available at 26-28 weeks of gestation and may not accurately reflect postnatal status given that choline levels have previously shown to increase during pregnancy and decrease after birth (Velzing-Aarts et al., 2005) . Multiple assessments of these plasma markers over the course of pregnancy could provide useful insight into how the maternal choline and betaine levels across pregnancy may affect the outcome of our study differently. Moreover, as all observational studies, we cannot exclude the possibility of residual confounding by unmeasured or poorly measured covariates.
For example, no information was available on possible changes in antidepressive drug use. Nevertheless, we included many covariates known for their association with depression, and choline or betaine.
Lastly, as we excluded persons who self-reported preexisting mental disorders, results of our study might not be generalizable to populations with more severe symptoms of depression and anxiety. Further research in clinically depressed or anxious women during the perinatal period is warranted.
IMPLICATIONS AND FUTURE RESEARCH
We observed that higher antenatal plasma choline concentrations were associated with more depression and anxiety symptoms during pregnancy, whereas plasma betaine concentrations showed no associ- Model 1: unadjusted. Model 2: adjusted for prepregnancy regular smoking (y/n), maternal age (y), ethnicity (Chinese, Malay, Indian), educational level (primary and secondary, post-secondary, university), income (<S$1,999, 2,000-5,999, >S$6,000), and antenatal scores. Zeisel, 2013) and suggest caution for relative high choline concentrations in relation to mental health. Prospective studies are required to replicate these findings and study the causality of these associations.
More research is, moreover, needed to investigate potential dietary food sources that contribute to higher choline concentrations during pregnancy for future dietary interventions and potential prevention of mental illnesses. Lastly, future studies should also focus on the subsequent effect of maternal choline status on offspring mental well-being, as it recently has been shown in an animal study that perinatal maternal choline supplementation could ameliorate the effects of prenatal stress on anxiety-related behavior in offspring (Schulz et al., 2014) .
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